Mizuho Securities USA LLC Boosts Position in Kenvue Inc. (NYSE:KVUE)

Mizuho Securities USA LLC lifted its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 46.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 181,712 shares of the company's stock after purchasing an additional 57,524 shares during the period. Mizuho Securities USA LLC's holdings in Kenvue were worth $3,880,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the company. FMR LLC lifted its position in shares of Kenvue by 2.3% during the 3rd quarter. FMR LLC now owns 137,915,493 shares of the company's stock worth $3,189,985,000 after purchasing an additional 3,075,019 shares during the last quarter. State Street Corp raised its holdings in shares of Kenvue by 16.8% in the 3rd quarter. State Street Corp now owns 127,213,940 shares of the company's stock worth $2,942,458,000 after buying an additional 18,283,473 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Kenvue by 0.9% during the third quarter. Geode Capital Management LLC now owns 44,677,077 shares of the company's stock valued at $1,029,810,000 after acquiring an additional 399,846 shares during the period. Harris Associates L P boosted its position in Kenvue by 7.5% in the third quarter. Harris Associates L P now owns 31,459,511 shares of the company's stock valued at $727,658,000 after buying an additional 2,186,114 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Kenvue by 2.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 24,972,777 shares of the company's stock worth $533,169,000 after acquiring an additional 561,570 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Evercore ISI assumed coverage on shares of Kenvue in a research report on Monday. They issued an "in-line" rating and a $25.00 price objective for the company. Canaccord Genuity Group raised their target price on Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a report on Wednesday, March 5th. UBS Group reduced their price target on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating on the stock in a research report on Friday, February 7th. Royal Bank of Canada restated a "sector perform" rating and set a $24.00 target price on shares of Kenvue in a report on Monday, February 3rd. Finally, Deutsche Bank Aktiengesellschaft cut Kenvue from a "buy" rating to a "hold" rating and reduced their price objective for the stock from $25.00 to $24.00 in a research report on Thursday, December 12th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $24.00.

Kenvue Trading Up 0.5 %

Shares of NYSE KVUE traded up $0.12 during mid-day trading on Thursday, hitting $23.52. The stock had a trading volume of 13,790,573 shares, compared to its average volume of 16,136,490. The business has a 50 day moving average price of $22.22 and a two-hundred day moving average price of $22.45. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $24.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The firm has a market cap of $44.95 billion, a P/E ratio of 44.38, a price-to-earnings-growth ratio of 2.62 and a beta of 1.25.

Kenvue (NYSE:KVUE - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $0.26 EPS for the quarter, meeting analysts' consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. On average, equities analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th were paid a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.49%. The ex-dividend date of this dividend was Wednesday, February 12th. Kenvue's dividend payout ratio is 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.